Literature DB >> 29057464

Successful treatment of refractory cholinergic urticaria with omalizumab.

Dimitra Koumaki1, Edward D Seaton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29057464     DOI： 10.1111/ijd.13808

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

Review 1.  Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.

Authors:  Désirée E S Larenas-Linnemann; Claudio A S Parisi; Carla Ritchie; Ricardo Cardona-Villa; Ivan Cherrez-Ojeda; Annia Cherrez; Luis Felipe Ensina; Elizabeth Garcia; Iris V Medina; Mónica Rodríguez-González; Jorge Mario Sánchez Caraballo
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-09       Impact factor: 4.806

Review 2.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

3.  Heater-Associated Erythema Ab Igne: Case Report and Review of Thermal-Related Skin Conditions.

Authors:  Parnia Forouzan; Ryan R Riahi; Philip R Cohen
Journal:  Cureus       Date:  2020-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.